The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 06, 2016

Filed:

Mar. 18, 2011
Applicants:

Karin Jarverud, Solna, SE;

Anders Bjorling, Solna, SE;

Malin Hollmark, Solna, SE;

Kjell Noren, Solna, SE;

Tomas Svensson, Stockholm, SE;

Stefan Hjelm, Balsta, SE;

Inventors:

Karin Jarverud, Solna, SE;

Anders Bjorling, Solna, SE;

Malin Hollmark, Solna, SE;

Kjell Noren, Solna, SE;

Tomas Svensson, Stockholm, SE;

Stefan Hjelm, Balsta, SE;

Assignee:

St. Jude Medical AB, Jarfalla, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/50 (2006.01); G06F 19/00 (2011.01); A61B 5/053 (2006.01); A61N 1/365 (2006.01); G06F 19/24 (2011.01); G06F 19/12 (2011.01); A61B 5/0464 (2006.01);
U.S. Cl.
CPC ...
G06F 19/34 (2013.01); A61B 5/0538 (2013.01); A61N 1/36521 (2013.01); G06F 19/3437 (2013.01); A61B 5/0464 (2013.01); A61N 1/36535 (2013.01); G06F 19/12 (2013.01); G06F 19/24 (2013.01);
Abstract

A patient-specific hemodyanmic status model is determined from impedance data collected during periods of normal and abnormal hemodynamic status by deriving parameter values of a set of multiple impedance-derivable parameters from impedance signals collected during periods of normal hemodynamic status and in connection with periods of abnormal hemodynamic status. The parameter values are employed to estimate coefficients of a linear parametric status model. These coefficients can then be used together with parameter values determined from impedance signals determined during status assessment periods in order to determine a current hemdoynamic status of the patient.


Find Patent Forward Citations

Loading…